Funding Opportunities in the Life Sciences

Click to view our current database of Funding Opportunities in the Life Sciences.

| 1 min read

Listen with Speechify

0:00

1:00

Click to view our current database of Funding Opportunities in the Life Sciences.

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here

Published In

February 2002

View Issue

Screening 3D Brain Cell Cultures for Drug Discovery

Webinar

The Holy Grail Hunt in De Novo Antibody Design

Article

Conceptual 3D image of a multicolored membrane protein on a black background.

Making the Most of Membrane Protein Production

Article

An image of a glowing hexagonal pattern on a dark background.

Enhancing Sequencing-Based Genotyping with Enrichment Panels

Article

July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue

Research Resources

Screening 3D Brain Cell Cultures for Drug Discovery

In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.

Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

An improved chromatography membrane elution method helps scientists achieve higher yields of pure plasmid DNA.

An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.

Products

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.

Introducing the iQue 5 HTS Platform: Empowering Scientists with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

New fluidics and clog detection systems further simplify operation and reduce instrument downtime

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

Study identifies new metrics to enhance scRNA-seq based virtual cell modelling

Funding Opportunities in the Life Sciences

Become a Member of

Published In

February 2002

Related Research Resources

What Causes an Earworm?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Screening 3D Brain Cell Cultures for Drug Discovery

Weaving the Fabric of Cancer Research with Synthetic DNA

Enhancing Elution of Plasmid DNA

Maximizing Lentivirus Recovery

Products

Product News

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

Introducing the iQue 5 HTS Platform: Empowering Scientists with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery